Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antimalarial efficacy study in children with uncomplicated falciparum malaria in Dolisie
ACTRN12616001422415Phase 4Completed
- Sponsor
- Ministry of Health and Population
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of artesunate, amodiaquine, artemether and lumefantrine in malaria and Falciparum malaria (PF) (2 cohorts), sponsored by Ministry of Health and Population. Primary endpoints: Treatment failure rate, Adequate clinical and parasitological response and 2 more. Started Jan 2017; status: completed.
02
Drugs
artesunateamodiaquineartemetherlumefantrine
03
Conditions
malariaFalciparum malaria (PF)
Beyond the preview
Go deeper on ACTRN12616001422415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001422415.